These slides should be reviewed with the accompanying prepared remarks posted on our website. Forward-looking statements The information in this release and other statements by the company may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to, among other items: projections and estimates of earnings, revenues, volumes, pricing, margins, sales, cost reductions, expenses, taxes, liquidity, capital expenditures, cash flow, dividends, share rep ...

分组1 - Eastman Chemical reported quarterly earnings of $0.75 per share, missing the Zacks Consensus Estimate of $0.76 per share, and down from $1.87 per share a year ago, representing an earnings surprise of -1.68% [1] - The company posted revenues of $1.97 billion for the quarter, missing the Zacks Consensus Estimate by 3.15%, and down from $2.25 billion year-over-year [2] - Over the last four quarters, Eastman Chemical has surpassed consensus EPS estimates only once and has not beaten consensus revenue estimates [2] 分组2 - The stock has gained about 8.2% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] - The current consensus EPS estimate for the coming quarter is $1.24 on revenues of $2.19 billion, and for the current fiscal year, it is $5.99 on revenues of $8.86 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 14% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

Financial Performance - Sales revenue for Q4 2025 decreased by 12% to $1,973 million compared to Q4 2024, driven by an 11% lower sales volume/mix and a 2% decrease in selling prices[3]. - Adjusted EBIT for FY 2025 was $930 million, down from $1,298 million in FY 2024, reflecting challenges in sales volume and price-cost dynamics[3]. - Sales revenue for FY 2025 decreased by 7% to $8,752 million, primarily due to a 6% lower sales volume/mix and a 1% decrease in selling prices[15]. - Eastman reported Q4 2025 sales of $1,973 million, a decrease of 12% compared to Q4 2024 sales of $2,245 million[44]. - For the full year 2025, Eastman generated revenue of approximately $8,752 million, down from $9,382 million in 2024, reflecting a 7% decline[44]. - Gross profit for Q4 2025 was $338 million, down from $554 million in Q4 2024, indicating a significant reduction in profitability[44]. - The company’s net earnings for Q4 2025 were $105 million, compared to $331 million in Q4 2024, representing a decline of 68%[44]. - For the full year 2025, GAAP net earnings were $474 million, translating to $4.10 per diluted share, compared to $905 million and $7.67 per share in 2024[73]. - Non-GAAP net earnings for 2025 reached $627 million, with a 13% effective tax rate, compared to $931 million in 2024, resulting in adjusted diluted earnings per share of $5.42[73]. - Net earnings for Q4 2025 were $105 million, a decrease from $331 million in Q4 2024, while total net earnings for the twelve months were $475 million compared to $908 million in the previous year[79]. Cash Flow and Investments - Operating cash flow approached $1 billion in 2025, a decrease from approximately $1.3 billion in 2024, indicating strong cash generation despite a challenging environment[5][26]. - Net cash provided by operating activities in Q4 2025 was $502 million, down from $540 million in Q4 2024, with total cash provided for the year at $970 million compared to $1,287 million in 2024[79]. - The company experienced a net cash used in investing activities of $47 million in Q4 2025, compared to $132 million in Q4 2024, with total cash used for the year at $462 million versus $534 million in 2024[79]. - Cash and cash equivalents at the end of Q4 2025 were $566 million, down from $837 million at the end of Q4 2024[79]. - The company reported a net change in cash and cash equivalents of $77 million in Q4 2025, a decrease from $215 million in Q4 2024, resulting in a total cash change of $(271) million for the year compared to $289 million in 2024[79]. Cost Management and Savings - Cost reduction initiatives exceeded targets, achieving approximately $100 million in savings against a goal of over $75 million[5]. - For 2026, the company plans to increase cost structure reduction actions to a range of $125 million to $150 million, building on previous initiatives[27]. - The company incurred asset impairments and restructuring charges of $54 million in Q4 2025, compared to $10 million in Q4 2024[59]. - The company incurred $96 million in asset impairments and restructuring charges in 2025, impacting net earnings significantly[73]. Segment Performance - Advanced Materials segment sales decreased by 9% in Q4 2025 compared to Q4 2024, with sales of $656 million down from $720 million[46]. - Chemical Intermediates segment experienced a 17% decline in sales in Q4 2025, with revenue of $418 million compared to $503 million in Q4 2024[46]. - The Fibers segment saw a significant 27% drop in sales in Q4 2025, with revenue of $234 million compared to $321 million in Q4 2024[46]. - The Advanced Materials segment's EBIT was $41 million in Q4 2025, a decrease from $107 million in Q4 2024, with a full year EBIT of $319 million compared to $442 million in 2024[57]. - The Additives & Functional Products segment achieved EBIT of $94 million in Q4 2025, down from $128 million in Q4 2024, with a full year EBIT of $512 million, up from $487 million[57]. - The Chemical Intermediates segment reported a loss of $50 million in Q4 2025, compared to a profit of $20 million in Q4 2024, with a full year loss of $60 million versus a profit of $101 million in 2024[57]. - The Fibers segment's EBIT was $47 million in Q4 2025, down from $103 million in Q4 2024, with a full year EBIT of $283 million compared to $454 million in 2024[57]. Future Outlook - The company expects first-quarter 2026 adjusted EPS to be between $1.00 and $1.20, driven by improved volume/mix and reduced shutdown costs[28]. - The company anticipates improved manufacturing utilization and fewer shutdowns in 2026, alongside potential tailwinds from foreign currency exchange rates[27].

Core Viewpoint - Eastman Chemical Company is experiencing fluctuations in analysts' price targets, reflecting changing expectations regarding its stock performance and potential investment opportunities [1][2][6] Price Target Summary - The average price target for Eastman Chemical has increased slightly from $71.33 to $72 over the last quarter, but has decreased from $73.43 a year ago, indicating a downward trend in analysts' expectations [2] - Wolfe Research has set a more optimistic price target of $114, suggesting a positive outlook for the company's growth despite the overall decline in expectations [3][5] Earnings Forecast - Eastman Chemical is expected to report its fourth-quarter 2025 earnings on January 29th, with forecasts of $0.79 per share and $2 billion in revenue, although a decline in earnings is anticipated [3][6] Market Conditions - The company's performance is influenced by key markets such as transportation, personal care, and construction, which are affected by broader economic factors [4] - Despite a 23% decline in stock value over the past year, Eastman Chemical's valuations and dividends remain attractive to investors, presenting a potential investment opportunity [4][6] Strategic Initiatives - Strategic initiatives and product developments are expected to impact analysts' views positively, with annual dividend payments being a significant factor for income-focused investors [5]

Core Viewpoint - Euro Manganese Inc. has confirmed that its management is unaware of any material changes in operations that would explain the recent increase in market activity, as requested by the Canadian Investment Regulatory Organization [1]. Company Overview - Euro Manganese Inc. is a battery materials company focused on developing the Chvaletice Manganese Project in the Czech Republic, which is recognized as Europe's only near-term source of high-purity manganese, essential for electric vehicles, energy storage batteries, and defense applications [3]. - The Chvaletice Manganese Project aims to reprocess historic mine tailings to produce high-purity electrolytic manganese metal (HPEMM) and high-purity manganese sulfate monohydrate (HPMSM), establishing a low-carbon supply chain within the European Union [4]. Production and Market Position - The company has successfully produced on-spec products at its Demonstration Plant, with ongoing optimization efforts to enhance the efficiency of its commercial plant, positioning Euro Manganese to become Europe's first domestic producer of high-purity manganese [5]. - The company is addressing the rising demand for sustainable battery materials while contributing to Europe's clean-energy and supply-chain independence goals [5].

Core Viewpoint - Eastman Chemical Company (EMN) is positioned as a mid-cap proxy for the global materials market, with 60% of its sales generated outside the US [1] Company Overview - Eastman Chemical Company is recognized as a specialty materials stalwart, indicating its strong presence and expertise in the materials sector [1] Market Position - The company’s significant international sales highlight its global reach and potential resilience against domestic market fluctuations [1]

Core Viewpoint - Eastman Chemical Company (EMN) is positioned as a mid-cap proxy for the global materials market, with 60% of its sales generated outside the United States [1] Company Summary - Eastman Chemical Company is recognized as a significant player in the specialty materials sector, indicating its relevance in the broader materials market [1]

Core Viewpoint - Euro Manganese Inc. announces changes to its Board of Directors, highlighting the resignation of Mr. John Webster after over ten years of service, which has been significant for the company's governance and strategic direction [2]. Company Overview - Euro Manganese Inc. is a battery materials company focused on developing the Chvaletice Manganese Project in the Czech Republic, which is positioned as Europe's only near-term source of high-purity manganese, essential for electric vehicles and energy storage [3][4]. Project Details - The Chvaletice Manganese Project aims to reprocess historic mine tailings to produce high-purity electrolytic manganese metal (HPEMM) and high-purity manganese sulphate monohydrate (HPMSM), establishing a low-carbon supply chain within the European Union [4]. - The company has successfully produced on-spec products at its Demonstration Plant and is working on optimizing commercial plant efficiency, positioning itself as Europe's first domestic producer of high-purity manganese [5].

Financial Results Release - The company will release its financial results on January 29, 2026, at approximately 4:15 p.m. Eastern Time [1] - The results will be distributed via wire and available on the company's website and SEC Form 8-K filing [1] Advance Slides, Webcast and Teleconference - An advance presentation will be available on January 30, 2026, at 8:00 a.m. Eastern Time through a live webcast and teleconference [2] - Participants can pre-register for the teleconference to receive unique dial-in information via email [3] Replay Information - A replay of the webcast will be available for download in MP3 format at the company's investor relations website [3] - Telephone replay will be accessible from January 31, 2026, at 1:00 p.m. Eastern Time until February 9, 2026, at 11:59 p.m. Eastern Time, with a toll-free number provided [4] Additional Resources - Advance slides and prepared remarks will be posted on the company's investor relations website on the evening of January 29, 2026 [5] - The teleconference will have a toll-free dial-in number and a passcode for participants [5]

Core Viewpoint - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends to shareholders [1] Group 1: Sonoco Products Co (NYSE:SON) - Dividend yield is 4.65% [6] - Analyst George Staphos from B of A Securities upgraded the stock from Neutral to Buy, raising the price target from $56 to $60 [6] - Analyst Gabe Hajde from Wells Fargo maintained an Overweight rating and increased the price target from $50 to $52 [6] - Recent news includes the completion of the sale of ThermoSafe unit to Arsenal Capital Partners on Nov. 3 [6] Group 2: Eastman Chemical Co (NYSE:EMN) - Dividend yield is 5.19% [6] - Analyst Michael Sison from Wells Fargo downgraded the stock from Overweight to Equal-Weight with a price target of $70 [6] - Analyst Patrick Cunningham from Citigroup maintained a Buy rating and raised the price target from $70 to $72 [6] - Recent news indicates that Eastman Chemical posted downbeat quarterly results on Nov. 3 [6] Group 3: Ternium SA (NYSE:TX) - Dividend yield is 6.94% [6] - Analyst Alfonso Salazar from Scotiabank maintained a Sector Outperform rating but cut the price target from $41 to $40 [6] - Analyst Timna Tanners from Wells Fargo initiated coverage with an Underweight rating and a price target of $30 [6] - Recent news shows that Ternium posted mixed quarterly results on Oct. 28 [6]